We are live on ! Find out more
PA

Perceptive Advisors Portfolio holdings

AUM $6.66B
1-Year Est. Return 360.84%
This Fund
S&P 500
This Quarter Est. Return
+20.93%
1 Year Est. Return
+360.84%
3 Year Est. Return
+1,707.27%
5 Year Est. Return
+3,210.42%
10 Year Est. Return
+53,055.89%
AUM
$952M
AUM Growth
+$119M
Cap. Flow
-$4.06M
Cap. Flow %
-0.43%
Top 10 Hldgs %
45.23%
Holding
168
New
60
Increased
16
Reduced
31
Closed
41

Top Buys

Rank Stock Value
1
HRTX icon
Heron Therapeutics
HRTX
+$23.5M
2
PTCT icon
PTC Therapeutics
PTCT
+$18.1M
3
ACAD icon
Acadia Pharmaceuticals
ACAD
+$16.8M
4
TVTX icon
Travere Therapeutics
TVTX
+$16.1M
5
SGMO
SANGAMO THERAPEUTICS INC
SGMO
+$15.4M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$48M
2
AEGR
Aegerion Pharmaceuticals
AEGR
+$31.8M
3
MNKD icon
MannKind Corp
MNKD
+$19.8M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$18.2M
5
SRPT icon
Sarepta Therapeutics
SRPT
+$15.4M

Sector Composition

Rank Sector Weight
1 Healthcare 81.36%
2 Miscellaneous 16.85%
3 Consumer Staples 1.74%
4 Technology 0.04%
5 Industrials 0.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HTWR
151
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
– –
-84,900
Closed -$7.98M
NSPH
152
DELISTED
NANOSPHERE INC. COM NEW
NSPH
– –
-14,750
Closed -$676K
AFFX
153
DELISTED
Affymetrix Inc
AFFX
– –
-8,538
Closed -$73K
TRNX
154
DELISTED
TORNIER N V SHARES (NLD)
TRNX
– –
-10,000
Closed -$188K
ZGNX
155
DELISTED
Zogenix, Inc.
ZGNX
– –
-81,250
Closed -$2.24M
AUXL
156
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
– –
-100,000
Closed -$2.07M
GENT
157
DELISTED
GENTIUM SPA ADS
GENT
– –
-120,000
Closed -$6.85M
SNTS
158
DELISTED
SANTARUS INC
SNTS
– –
-45,400
Closed -$1.45M
CTIC
159
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
– –
-371,500
Closed -$7.13M
TBIO
160
DELISTED
TRANGSGENOMIC INC
TBIO
– –
-2,207,500
Closed -$1M
RPRX
161
DELISTED
Repros Therapeutics Inc.
RPRX
– –
-71,879
Closed -$1.31M
3 4 5 6
7

Similar funds

QP
Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return
FCBT
First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return
RWM
Ritholtz Wealth Management New York $6.7B AUM 32.7% 1-Year Est. Return
AWA
Arkadios Wealth Advisors Atlanta, Georgia $6.6B AUM 30.67% 1-Year Est. Return
WHRC
W.H. Reaves & Co Jersey City, New Jersey $6.59B AUM 31.9% 1-Year Est. Return
KGA
K5 Global Advisor Miami Beach, Florida $6.59B AUM
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $6.74B AUM 30.22% 1-Year Est. Return

Perceptive Advisors's Q1 2014 Portfolio in Review

As of Q1 2014, Perceptive Advisors held 168 positions worth $952M, up 14% from $833M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Perceptive Advisors's Q1 2014 filing shows 60 new, 16 increased, 31 reduced and 41 closed positions. Its largest new stake was Heron Therapeutics: 1,762,426 shares worth $24.5M. The largest sale was Celgene Corp, an estimated $48M.

By sector, the portfolio is most concentrated in Healthcare at 81% of assets, down from 85% a quarter earlier, followed by Miscellaneous and Consumer Staples.

  • Perceptive Advisors's largest Q1 2014 buy was Heron Therapeutics: 1,762,426 shares worth $24.5M.
  • Perceptive Advisors added most to Clovis Oncology, Inc. in Q1 2014, an estimated $10.4M increase.
  • Perceptive Advisors's biggest Q1 2014 reduction was Celgene Corp, cutting an estimated $48M.
  • Perceptive Advisors fully exited Aegerion Pharmaceuticals in Q1 2014, selling an estimated $31.8M.
  • Perceptive Advisors's ten largest holdings make up 45% of its $952M portfolio in Q1 2014.
  • Perceptive Advisors opened 60 new positions and closed 41 in Q1 2014.
  • Perceptive Advisors's portfolio value rose 14% quarter-over-quarter to $952M.

Based on Perceptive Advisors's 13F filing for Q1 2014, filed 15 May 2014.